HEALWELL AI INC. Financials Healwell AI Inc. OTC Markets
Equities
HWAI.F
CA42249X1006
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.72 USD | +0.29% |
|
-16.50% | +213.24% |
| 06-26 | Healwell AI Backs Musk-founded X.AI With US$2 Million Investment | MT |
| 06-26 | X.AI Corp. announced that it has received $2 million in funding from Healwell AI Inc. | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 61.13 | 30.05 | 65.99 | 312.3 | - | - |
| Enterprise Value (EV) 1 | 55.71 | 35.67 | 65.99 | 312.3 | 312.3 | 312.3 |
| P/E ratio | -3.79 x | -1.43 x | -1.36 x | -12.6 x | -24.6 x | -78 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.28 x | 0.56 x | 9.02 x | 7.58 x | 4.31 x | 3.99 x |
| EV / Revenue | 1.28 x | 0.56 x | 9.02 x | 7.58 x | 4.31 x | 3.99 x |
| EV / EBITDA | -13.2 x | -3.21 x | -8.3 x | -34.2 x | -128 x | 50.3 x |
| EV / FCF | -7.71 x | -3.47 x | - | -21.4 x | -23.8 x | - |
| FCF Yield | -13% | -28.8% | - | -4.67% | -4.19% | - |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 48,905 | 50,075 | 87,987 | 133,476 | - | - |
| Reference price 2 | 1.250 | 0.6000 | 0.7500 | 2.340 | 2.340 | 2.340 |
| Announcement Date | 31/03/22 | 31/03/23 | 28/03/24 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 46.29 | 38.57 | 47.82 | 53.22 | 7.317 | 41.21 | 72.44 | 78.33 |
| EBITDA 1 | - | 4.518 | -4.644 | -9.356 | -7.954 | -9.139 | -2.438 | 6.213 |
| EBIT 1 | - | -3.294 | -15.06 | - | -16.82 | -18.92 | -13.33 | -4.667 |
| Operating Margin | - | -8.54% | -31.5% | - | -229.85% | -45.91% | -18.4% | -5.96% |
| Earnings before Tax (EBT) 1 | - | - | -16.29 | - | -32.68 | -22.97 | -18.15 | -4.823 |
| Net income 1 | -0.1203 | - | -15.67 | - | -31.54 | -22.14 | -17.76 | -4.553 |
| Net margin | -0.26% | - | -32.77% | - | -431.12% | -53.73% | -24.52% | -5.81% |
| EPS 2 | - | - | -0.3300 | -0.4200 | -0.5500 | -0.1850 | -0.0950 | -0.0300 |
| Free Cash Flow 1 | - | 4.137 | -7.931 | -8.658 | - | -14.6 | -13.1 | - |
| FCF margin | - | 10.73% | -16.59% | -16.27% | - | -35.43% | -18.08% | - |
| FCF Conversion (EBITDA) | - | 91.57% | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 11/12/20 | 30/03/21 | 31/03/22 | 31/03/23 | 28/03/24 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 13.94 | 13.02 | 13.81 | 12.59 | 13.8 | - | 2.753 | 1.921 | 4.579 | 5.419 | 14.38 | 16.39 | 16.59 | 17.07 |
| EBITDA 1 | -1.514 | -2.421 | -2.936 | -2.152 | -1.789 | - | -4.535 | -1.464 | -2.562 | -2.954 | -2.185 | -1.672 | -1.212 | -0.813 |
| EBIT 1 | -4.551 | -4.763 | -5.064 | -5.119 | - | - | - | -3.886 | - | -5.05 | -4.274 | -4.158 | -3.879 | -3.48 |
| Operating Margin | -32.66% | -36.58% | -36.66% | -40.67% | - | - | - | -202.29% | - | -93.19% | -29.72% | -25.37% | -23.38% | -20.39% |
| Earnings before Tax (EBT) 1 | -4.691 | -5.037 | -5.445 | -5.588 | - | - | -7.771 | -6.107 | -6.509 | -5.758 | -5.573 | -5.134 | -4.118 | -3.619 |
| Net income 1 | -4.94 | -4.322 | -4.229 | -9.1 | - | -9.805 | -7.791 | -6.311 | -5.927 | -5.598 | -5.438 | -5.005 | -3.888 | -3.417 |
| Net margin | -35.45% | -33.2% | -30.61% | -72.3% | - | - | -283% | -328.53% | -129.44% | -103.29% | -37.82% | -30.54% | -23.44% | -20.02% |
| EPS 2 | -0.1000 | -0.0900 | -0.0800 | -0.1800 | -0.0700 | -0.1800 | - | -0.0900 | -0.0600 | -0.0500 | -0.0400 | -0.0350 | -0.0300 | -0.0300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/08/23 | 14/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | 5.62 | - | - | - | - |
| Net Cash position | - | - | 5.42 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.601 x | - | - | - | - |
| Free Cash Flow 1 | - | 4.14 | -7.93 | -8.66 | - | -14.6 | -13.1 | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 0.09 | 0.83 | 0.31 | 0.07 | 1.49 | 1.67 | 1.84 |
| Capex / Sales | - | 0.22% | 1.74% | 0.59% | 0.9% | 3.62% | 2.31% | 2.35% |
| Announcement Date | 11/12/20 | 30/03/21 | 31/03/22 | 31/03/23 | 28/03/24 | - | - | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.34
CAD
Average target price
3.95
CAD
Spread / Average Target
+68.80%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -32.30% | 13.37B | |
| +3.98% | 11.75B | |
| -3.60% | 11.57B | |
| +7.59% | 10.85B | |
| +26.78% | 8.55B | |
| -11.50% | 7.24B | |
| +7.53% | 6.84B | |
| +8.77% | 6.5B | |
| 0.00% | 4.4B |
- Stock Market
- Equities
- AIDX Stock
- HWAI.F Stock
- Financials Healwell AI Inc.
